|
Current tenofovir PREP Studies |
||||
| Study Location |
Population Group |
Sponsor |
Study Goal |
Expected Initial Results |
|
|
||||
| Cambodia |
Commercial sex workers 960 volunteers |
NIH |
Safety & efficacy |
2007 |
| Cameroon, Ghana |
High-risk women 800 volunteers |
FHI |
Safety & efficacy |
2007 |
| Malawi |
High-risk men 500 volunteers |
FHI |
Safety & efficacy |
2007 |
| Botswana |
Young adults 1,200 volunteers |
CDC |
Safety &efficacy |
2007 |
| Thailand |
Injection drug users 1,600 volunteers |
CDC |
Safety & efficacy |
2007 |
| United States |
Men who have sex with men |
CDC |
Safety |
2007 |
| Peru |
Men who have sex with men 2,100 volunteers |
NIH |
Safety & efficacy |
2008 |
Mills et al. BMC International Health and Human Rights 2005 5:6 doi:10.1186/1472-698X-5-6 |
||||